Corporate Press ReleaseIchnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001NewsmantraDecember 10, 2024 by NewsmantraDecember 10, 20240 Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™...